Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib Combined with Acitretin for Primary Cutaneous Amyloidosis
NCT06998875Phase 4Recruiting
- Sponsor
- Army Medical University
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofacitinib in primary cutaneous amyloidosis (PCA), sponsored by Army Medical University. Started Mar 2025; status: recruiting.
02
Drugs
03
Conditions
primary cutaneous amyloidosis (PCA)
Beyond the preview
Go deeper on NCT06998875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06998875.